APO RESEARCH · REPORT
Famciclovir API
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
Product & engineering
Understand the product.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
Selected research
Industry Research
Famciclovir API Industry Research Report 2026
Market perspective
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Read the full market overview
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report quantifies the global Famciclovir API market in terms of revenue (US$ million) and, where applicable, sales volume (KG), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/KG) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Famciclovir API Market by Company
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Famciclovir API Segment by Type
Insourced
Outsourced
Others
Famciclovir API Segment by Application
Tablet Product
Capsule Product
Others
Famciclovir API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famciclovir API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Famciclovir API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Famciclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Insourced
- Outsourced
- Others
Applications
- Tablet Product
- Capsule Product
- Others
Companies covered
- Chongqing Shenghuaxi Pharma
- Aurobindo Pharma Limited
- Apotex Pharmachem
- Changzhou Kony Pharma Co
- Teva Pharmaceutical Industries
- Olon
- Fuan Pharmaceutical
- Zhejiang Charioteer Pharmaceutical
- Jialin Pharmaceutical
- Zhejiang Hisun
- Hetero
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Famciclovir API Market Size (2021-2032)
- 2.2.2 Global Famciclovir API Sales (2021-2032)
- 2.2.3 Global Famciclovir API Market Average Price (2021-2032)
- 2.3 Famciclovir API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Insourced
- 2.3.3 Outsourced
- 2.3.4 Others
- 2.4 Famciclovir API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet Product
- 2.4.3 Capsule Product
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Famciclovir API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Famciclovir API Sales (KG) of Manufacturers (2021-2026)
- 3.3 Global Famciclovir API Revenue of Manufacturers (2021-2026)
- 3.4 Global Famciclovir API Average Price by Manufacturers (2021-2026)
- 3.5 Global Famciclovir API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Famciclovir API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Famciclovir API, Product Type & Application
- 3.8 Global Manufacturers of Famciclovir API, Established Date
- 3.9 Global Famciclovir API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Shenghuaxi Pharma
- 4.1.1 Chongqing Shenghuaxi Pharma Company Information
- 4.1.2 Chongqing Shenghuaxi Pharma Business Overview
- 4.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio
- 4.1.5 Chongqing Shenghuaxi Pharma Recent Developments
- 4.2 Aurobindo Pharma Limited
- 4.2.1 Aurobindo Pharma Limited Company Information
- 4.2.2 Aurobindo Pharma Limited Business Overview
- 4.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aurobindo Pharma Limited Famciclovir API Product Portfolio
- 4.2.5 Aurobindo Pharma Limited Recent Developments
- 4.3 Apotex Pharmachem
- 4.3.1 Apotex Pharmachem Company Information
- 4.3.2 Apotex Pharmachem Business Overview
- 4.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Apotex Pharmachem Famciclovir API Product Portfolio
- 4.3.5 Apotex Pharmachem Recent Developments
- 4.4 Changzhou Kony Pharma Co
- 4.4.1 Changzhou Kony Pharma Co Company Information
- 4.4.2 Changzhou Kony Pharma Co Business Overview
- 4.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Changzhou Kony Pharma Co Famciclovir API Product Portfolio
- 4.4.5 Changzhou Kony Pharma Co Recent Developments
- 4.5 Teva Pharmaceutical Industries
- 4.5.1 Teva Pharmaceutical Industries Company Information
- 4.5.2 Teva Pharmaceutical Industries Business Overview
- 4.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teva Pharmaceutical Industries Famciclovir API Product Portfolio
- 4.5.5 Teva Pharmaceutical Industries Recent Developments
- 4.6 Olon
- 4.6.1 Olon Company Information
- 4.6.2 Olon Business Overview
- 4.6.3 Olon Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Olon Famciclovir API Product Portfolio
- 4.6.5 Olon Recent Developments
- 4.7 Fuan Pharmaceutical
- 4.7.1 Fuan Pharmaceutical Company Information
- 4.7.2 Fuan Pharmaceutical Business Overview
- 4.7.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fuan Pharmaceutical Famciclovir API Product Portfolio
- 4.7.5 Fuan Pharmaceutical Recent Developments
- 4.8 Zhejiang Charioteer Pharmaceutical
- 4.8.1 Zhejiang Charioteer Pharmaceutical Company Information
- 4.8.2 Zhejiang Charioteer Pharmaceutical Business Overview
- 4.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio
- 4.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments
- 4.9 Jialin Pharmaceutical
- 4.9.1 Jialin Pharmaceutical Company Information
- 4.9.2 Jialin Pharmaceutical Business Overview
- 4.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jialin Pharmaceutical Famciclovir API Product Portfolio
- 4.9.5 Jialin Pharmaceutical Recent Developments
- 4.10 Zhejiang Hisun
- 4.10.1 Zhejiang Hisun Company Information
- 4.10.2 Zhejiang Hisun Business Overview
- 4.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zhejiang Hisun Famciclovir API Product Portfolio
- 4.10.5 Zhejiang Hisun Recent Developments
- 4.11 Hetero
- 4.11.1 Hetero Company Information
- 4.11.2 Hetero Business Overview
- 4.11.3 Hetero Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hetero Famciclovir API Product Portfolio
- 4.11.5 Hetero Recent Developments
5 Global Famciclovir API Market Scenario by Region
- 5.1 Global Famciclovir API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Famciclovir API Sales by Region: 2021-2032
- 5.2.1 Global Famciclovir API Sales by Region: 2021-2026
- 5.2.2 Global Famciclovir API Sales by Region: 2027-2032
- 5.3 Global Famciclovir API Revenue by Region: 2021-2032
- 5.3.1 Global Famciclovir API Revenue by Region: 2021-2026
- 5.3.2 Global Famciclovir API Revenue by Region: 2027-2032
- 5.4 North America Famciclovir API Market Facts & Figures by Country
- 5.4.1 North America Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Famciclovir API Sales by Country (2021-2032)
- 5.4.3 North America Famciclovir API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Famciclovir API Market Facts & Figures by Country
- 5.5.1 Europe Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Famciclovir API Sales by Country (2021-2032)
- 5.5.3 Europe Famciclovir API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Famciclovir API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Famciclovir API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Famciclovir API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Famciclovir API Market Facts & Figures by Country
- 5.7.1 South America Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Famciclovir API Sales by Country (2021-2032)
- 5.7.3 South America Famciclovir API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Famciclovir API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Famciclovir API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Famciclovir API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Famciclovir API Sales by Type (2021-2032)
- 6.1.1 Global Famciclovir API Sales by Type (2021-2032) & (KG)
- 6.1.2 Global Famciclovir API Sales Market Share by Type (2021-2032)
- 6.2 Global Famciclovir API Revenue by Type (2021-2032)
- 6.2.1 Global Famciclovir API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Famciclovir API Revenue Market Share by Type (2021-2032)
- 6.3 Global Famciclovir API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Famciclovir API Sales by Application (2021-2032)
- 7.1.1 Global Famciclovir API Sales by Application (2021-2032) & (KG)
- 7.1.2 Global Famciclovir API Sales Market Share by Application (2021-2032)
- 7.2 Global Famciclovir API Revenue by Application (2021-2032)
- 7.2.1 Global Famciclovir API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Famciclovir API Revenue Market Share by Application (2021-2032)
- 7.3 Global Famciclovir API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Famciclovir API Value Chain Analysis
- 8.1.1 Famciclovir API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Famciclovir API Production Mode & Process
- 8.2 Famciclovir API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Famciclovir API Distributors
- 8.2.3 Famciclovir API Customers
9 Global Famciclovir API Analyzing Market Dynamics
- 9.1 Famciclovir API Industry Trends
- 9.2 Famciclovir API Industry Drivers
- 9.3 Famciclovir API Industry Opportunities and Challenges
- 9.4 Famciclovir API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst